Method AI
Method AI provides AI-backed surgical navigation to help surgeons locate and remove tumors more accurately in robotic oncology procedures. The company builds a surgical navigation platform that uses artificial intelligence to analyze intraoperative data and guide robotic surgical workflows. It is positioned as a B2B medical software/hardware platform for hospitals, surgical oncology teams, and robotic surgery providers. Method AI targets the robotic surgical oncology market and aims to improve patient outcomes by enhancing precision and decision support during operations.
Method AI
Method AI provides AI-backed surgical navigation to help surgeons locate and remove tumors more accurately in robotic oncology procedures. The company builds a surgical navigation platform that uses artificial intelligence to analyze intraoperative data and guide robotic surgical workflows. It is positioned as a B2B medical software/hardware platform for hospitals, surgical oncology teams, and robotic surgery providers. Method AI targets the robotic surgical oncology market and aims to improve patient outcomes by enhancing precision and decision support during operations.
TL;DR
Product: AI-backed surgical navigation platform for robotic surgical oncology
Headquarters: Boston, Massachusetts, United States
Founding year: 2021
Latest stage: Series A (Aug 21, 2025)
Named investors: Cleveland Clinic; JobsOhio
Company Overview
Problem Domain
Robotic surgical oncology — locating and removing tumors with higher accuracy during operations.
Founded
2021
Industry
DeepTech